Skip to main content

cariprazine

Generic: CARIPRAZINE HYDROCHLORIDE·Brand: CARIPRAZINE HYDROCHLORIDE, VRAYLAR, Vraylar

cariprazine: sourced relationships with 1 company · 1 clinical trial tracked · 1 FDA decision.

cariprazine evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect cariprazine to ABBV; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could cariprazine → ABBV affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
AbbVie Inc. (ABBV)
Reported 2015-09-17 · Current development: unknownSource
Approved
Clinical Trial Registry Records (1)

A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 Years of Age) in the Treatment of Depressive Episodes Associated With Bipolar I Disorder

NCT04777357Registry updated 2026-07-27·Phase 3·ABBV
Recruiting

Primary endpoint: Number of Participants with Adverse Events

InterventionalRandomizedtriple380 targetStarted 2021-04Completion 2027-0350 sites · United StatesAbbVie
FDA Decisions1 records
Approval(ABBV)FDA ↗
NDA204370Type 1 - New Molecular EntityStandardOralCapsule

Frequently asked questions

Which companies have sourced relationships with cariprazine?

cariprazine has dated SEC/FDA relationship records for AbbVie Inc..

How many clinical trials involve cariprazine?

BioSniper tracks 1 clinical trial involving cariprazine.

What is cariprazine's latest FDA decision?

The most recent tracked FDA decision for cariprazine is Approval, dated September 17, 2015.